Rapid Influenza Diagnostics Market Size

Rapid Influenza Diagnostics Market size was valued at USD 921.75 million in 2024 and is anticipated to reach USD 2.56 billion by the end of 2037, expanding at around 8.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of rapid influenza diagnostics is assessed at USD 982.22 million. The growth of this market can be attributed to the growing prevalence of influenza all around the world. The increasing number of people globally found with weak immunity systems suffering from target ailments are expected to raise the industry growth in the forthcoming years. Human influenza viruses consisting of Type A and Type B influenza are the most significant viruses that cause disease risk in humans. These issues contribute to healthcare costs and also disrupt health-associated quality of life. As per a report by the World Health Organization, globally around 3 – 5 million people suffer from severe cases of influenza.

The increased R&D spending for the provision of technically advanced solutions to diagnose influenza is expected to lead to a higher rate of global adoption of these tests. The market revenue for these tests is expected to expand over the coming years due to the widespread use of rapid influenza diagnostic testing and a growing incidence of influenza.